Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.
NCT02132052 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81
Last updated 2021-06-25
Summary
Investigators hypothesize that there are specific characteristic of each cognitive and motor condition that can be defined using brains scans.
Conditions
- Essential Tremor
- Multiple System Atrophy
- Corticobasal Degeneration
- Supranuclear Palsy, Progressive
- Parkinson Disease
Sponsors & Collaborators
-
University of Colorado, Denver
lead OTHER
Principal Investigators
-
benzi Kluger, MD · University of Colorado, Denver
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of a Multimodal Neuroimaging Method for Diagnosis in Parkinsonian Syndromes
NCT02428816 ·Status: COMPLETED ·Phase: NA
-
Natural History Protocol for Movement Disorders
NCT05413291 ·Status: RECRUITING
-
Neuroimaging Studies of Depression in Parkinson's Disease
NCT00518258 ·Status: COMPLETED
-
Attention and Eye Movement in Parkinson's Disease
NCT06899022 ·Status: RECRUITING ·Phase: NA
-
Investigating the Microstructural and Functional Alterations of Brain in Parkinson's Disease Patients
NCT02599753 ·Status: COMPLETED ·Phase: PHASE2
-
MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.
NCT01547481 ·Status: COMPLETED
-
PET/MR Imaging in Patients With Short and Long Standing Parkinson's Disease
NCT02801110 ·Status: UNKNOWN
-
Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families
NCT00273351 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging in the Diagnosis of Parkinson's Disease and Essential Tremor
NCT01446939 ·Status: UNKNOWN
-
Identification of a Biomarker Predictive of Evolution of Parkinson Disease
NCT03230526 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
NCT04925622 ·Status: COMPLETED
-
Somatotopy in Parkinson's Disease
NCT04876404 ·Status: COMPLETED
-
Neuroplasticity in Parkinson's Disease
NCT05286736 ·Status: RECRUITING
-
Neural Correlates of Cognition in Parkinson's Disease
NCT02975193 ·Status: COMPLETED ·Phase: NA
-
Investigating Inhibitory Control Networks in Parkinson's Disease
NCT04735458 ·Status: RECRUITING ·Phase: NA
-
Movement Disorder Quantification Algorithm Development
NCT01534650 ·Status: COMPLETED
-
Evidence of Neuroplasticity After Performing a Cognitive Task in Idiopathic Parkinson's Disease Patients
NCT02494908 ·Status: UNKNOWN ·Phase: NA
-
Effect and Mechanism of Brain Stimulation for Parkinson's Disease With Cognitive Impairment
NCT06090682 ·Status: RECRUITING
-
Cognitive Phenotypes in Parkinson's Disease
NCT01792843 ·Status: COMPLETED
-
Electroencephalographic Signatures of Neuropsychiatric Fluctuations in Parkinson's Disease
NCT06301282 ·Status: RECRUITING
-
Diagnosis and Natural History Study of Patients With Neurological Conditions
NCT00001549 ·Status: COMPLETED
-
PET Study of Non-Motor Symptoms of Parkinson Disease
NCT01565473 ·Status: COMPLETED
-
Amyloid Beta and Cognition in Parkinson Disease
NCT01754168 ·Status: COMPLETED
-
Visual Selective Attention in Parkinson's Disease
NCT01135407 ·Status: COMPLETED
-
A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease
NCT03582137 ·Status: COMPLETED ·Phase: PHASE2